The Burn Glove Trial - Hand Burn Dressing Pilot (NCT02318056) | Clinical Trial Compass
WithdrawnNot Applicable
The Burn Glove Trial - Hand Burn Dressing Pilot
Stopped: Due to reorganization.
United States0Started 2015-12
Plain-language summary
Specific Aim 1: To determine if one of three burn dressings provides a less painful healing experience for partial thickness hand.
Specific Aim 2: To evaluate if one of three dressings provides greater functionality during and after healing of partial thickness hand burns.
Specific Aim 3: To determine if one of three burn dressings promotes aesthetically superior healing results for partial thickness hand burns.
Who can participate
Age range
8 Years – 60 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients presenting at Memorial Medical or Southern Illinois University (SIU) Health Care
* Patients with partial-thickness burn injuries to the dorsum and/or palm of the hand/s that exceeds ½% total body surface area (TBSA) for at least one hand.
* \< 10% TBSA 2nd and 3rd degree burn injuries
* Initial clinical presentation \< 5 days post burn injury
Exclusion Criteria:
* \< ½ % TBSA involving the hand
* \> 10%TBSA burn injuries
* \> 60 years of age
* \< 8 years of age
* Patients (or parents of minors) without cognitive capacity to comprehend informed consent
* Presentation \> 5 days post-burn injury event
* Pregnant women
* Full thickness/3rd degree burns to the dorsal and/or palmer hand/s
* Exposed vital structures (tendons, nerves, bone, vessels)
* Uncontrolled Type II Diabetes
* Type I Diabetes
* History of Chronic Obstructive Pulmonary Disease
* Have a known allergy to silver products
* Signs of infection on initial clinical presentation (presence of purulent drainage, significant cellulitis, and/or fever)
* Smoke/inhalation injuries requiring ventilation
* Critically ill patients requiring intensive care
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.